Akira Miyazaki

Advanced glycation end products (AGE) inhibit scavenger receptor class B type I-mediated reverse cholesterol transport: a new crossroad of AGE to cholesterol metabolism.

Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis.

Genomic organization, expression, and comparative analysis of noncoding region of the rat Ndrg4 gene.

[Acyl-coenzyme A: cholesterol acyltransferase (ACAT)].

High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia.

Serotonin acts as an up-regulator of acyl-coenzyme A:cholesterol acyltransferase-1 in human monocyte-macrophages.

Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages.

Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia.

Ndrg4 enhances NGF-induced ERK activation uncoupled with Elk-1 activation.

Inhibitors of acyl-coenzyme a: cholesterol acyltransferase.

Human urotensin II as a link between hypertension and coronary artery disease.

Impact of increased plasma serotonin levels and carotid atherosclerosis on vascular dementia.

Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension.

Human urotensin-II potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells: comparison with other vasoactive agents and hydrogen peroxide.

Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer's disease.

Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis.

Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.

Serum salusin-alpha levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients.

Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.

Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via the angiotensin II Type 1 receptor in human monocyte-macrophages.

Human urotensin II promotes hypertension and atherosclerotic cardiovascular diseases.

Leptin modulates ACAT1 expression and cholesterol efflux from human macrophages.

Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia.

Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis.

Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.

Purification of recombinant acyl-coenzyme A:cholesterol acyltransferase 1 (ACAT1) from H293 cells and binding studies between the enzyme and substrates using difference intrinsic fluorescence spectroscopy.

m-Calpain induction in vascular endothelial cells on human and mouse atheromas and its roles in VE-cadherin disorganization and atherosclerosis.

Effects of PKF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E-null mice.

Hydrogen peroxide-inducible clone 5 (Hic-5) as a potential therapeutic target for vascular and other disorders.

Coexpression of CCR6 and CD146 (MCAM) is a marker of effector memory T-helper 17 cells.

Salusin-β accelerates inflammatory responses in vascular endothelial cells via NF-κB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro.

Calpain and atherosclerosis.

Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein.

Identification of Hic-5 as a novel scaffold for the MKK4/p54 JNK pathway in the development of abdominal aortic aneurysms.

NADPH oxidase deficiency exacerbates angiotensin II-induced abdominal aortic aneurysms in mice.

Role of Hic-5 in the formation of microvilli-like structures and the monocyte-endothelial interaction that accelerates atherosclerosis.

Calpastatin counteracts pathological angiogenesis by inhibiting suppressor of cytokine signaling 3 degradation in vascular endothelial cells.

Hydrogen peroxide-inducible clone-5 regulates mesangial cell proliferation in proliferative glomerulonephritis in mice.

Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice.

Fibroblast growth factor-23 induces cellular senescence in human mesenchymal stem cells from skeletal muscle.

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Is Involved in Adult Mouse Hippocampal Neurogenesis After Stroke.

Functional Heterogeneity of Nadph Oxidases in Atherosclerotic and Aneurysmal Diseases.

Calpain-6 confers atherogenicity to macrophages by dysregulating pre-mRNA splicing.

Potential contribution of the hepcidin-macrophage axis to plaque vulnerability in acute myocardial infarction in human.

Differential lactate and cholesterol synthetic activities in XY and XX Sertoli cells.

Emerging roles of calpain proteolytic systems in macrophage cholesterol handling.

Dysregulation of Calpain Proteolytic Systems Underlies Degenerative Vascular Disorders.

The impact of stromal Hic-5 on the tumorigenesis of colorectal cancer through lysyl oxidase induction and stromal remodeling.

Expression of steroidogenic enzymes and metabolism of steroids in COS-7 cells known as non-steroidogenic cells.

Impact of Dysfunctional Protein Catabolism on Macrophage Cholesterol Handling.

Endothelial calpain systems orchestrate myofibroblast differentiation during wound healing.

Thrombolytic Therapy for Acute Ischemic Stroke: Past and Future.

Priming with erythropoietin enhances cell survival and angiogenic effect of mesenchymal stem cell implantation in rat limb ischemia.